Monica Khunger

Publications

Prasanna, P., Khorrami, M., Gupta, A., Patil, P., Khunger, M., Velu, P., Bera, K., Alilou, M., Velcheti, V., & Madabhushi, A. (2019). Intra and perinodular CT delta radiomic features associated with early response to predict overall survival (OS) in immunotherapy-treated non-small cell lung cancer (NSCLC): A multisite multi-agent study.. Journal of Clinical Oncology, 37 (15_suppl), 2588-2588.
Khorrami, M., Khunger, M., Zagouras, A., Patil, P., Thawani, R., Bera, K., Rajiah, P., Fu, P., Velcheti, V., & Madabhushi, A. (2019). Combination of Peri- and Intratumoral Radiomic Features on Baseline CT Scans Predicts Response to Chemotherapy in Lung Adenocarcinoma. Radiology: Artificial Intelligence, 1 (2).
WAng, X., Barrera, C., Velu, P., Bera, K., Prasanna, P., Khunger, M., Khunger, A., Velcheti, V., & Madabhushi, A. (2018). Computer extracted features of cancer nuclei from H&E stained tissues of tumor predicts response to nivolumab in non-small cell lung cancer.. Journal of Clinical Oncology, 36 (15_suppl), 12061-12061.
Barrera, C., Velu, P., Bera, K., WAng, X., Prasanna, P., Khunger, M., Khunger, A., Velcheti, V., Romero, E., & Madabhushi, A. (2018). Computer-extracted features relating to spatial arrangement of tumor infiltrating lymphocytes to predict response to nivolumab in non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology, 36 (15_suppl), 12115-12115.
Khorrami, M., Jain, P., Khunger, M., Ahmad, U., Stephans, K., Murthy, S., Velcheti, V., & Madabhushi, A. (2018). Combination of CT derived radiomic features and lymphovascular invasion status to predict disease recurrence following trimodality therapy in non-small cell lung cancer.. Journal of Clinical Oncology, 36 (15_suppl), e24314-e24314.
Patil, P., Bera, K., Vaidya, P., Prasanna, P., Khunger, M., Khunger, A., Velcheti, V., & Madabhushi, A. (2018). Correlation of radiomic features with PD-L1 expression in early stage non-small cell lung cancer (ES-NSCLC) to predict recurrence and overall survival (OS).. Journal of Clinical Oncology, 36 (15_suppl), e24247-e24247.